HOME >> BIOLOGY >> NEWS
Work with cancer-related proteins garners National Foundation for Cancer Research grant

potential to prevent cancer. Vanderbilt-Ingram scientists have uncovered evidence in the laboratory that suggests COX-2 inhibitors might be helpful in treating cancer as well. These drugs are based on minute differences in physical structure that permit fairly specific targeting of COX-2.

Marnett and his colleagues have recently discovered that endocannabinoid, 2-arachidonyl-glycerol (2-AG), is a substrate for COX-2 and is converted into a series of novel glyceryl-prostaglandins. COX-2 oxygenates natural derivatives of arachidonic acid such as esters and amides whereas COX-1 does not. "There is little difference between COX-1 and COX-2 at the protein level," Marnett said. "But for some reason, COX-1 is always present, while COX-2 only comes on when needed. It comes on like gangbusters, then goes away. Over the past year, we have identified a functional biochemical difference between the two proteins. If we can better understand that difference, we're hopeful that knowledge will allow us to exploit the difference to develop even more specific and effective drugs to prevent and potentially treat cancer."

"With NFCR's funding support, Dr. Marnett will be able to do bold and blue-sky exploration," said Dr. Sujuan Ba, Science Director of the National Foundation for Cancer Research. "We believe the findings from Dr. Marnett's research will aid in the development of the next generation of cancer preventive or therapeutic agents by identifying new molecular targets for drug development."

The National Foundation for Cancer Research is a cancer-related charity fully dedicated to advancing basic science cancer research in the laboratory. Formed in 1973 to support research related to the prevention, treatment and cure of cancer, NFCR encourages and facilitates collaboration and the sharing of ideas and results among scientists so that advances in one field contribute to discoveries in others. The NFCR has provided more than $170 million to fund research that h
'"/>

Contact: Cynthia Manley
cynthia.manley@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
25-Oct-2000


Page: 1 2 3

Related biology news :

1. Scientists identify molecular structure of cancer-related proteins
2. New molecular link key to cellular proteins involved in cancer progression, other diseases
3. New dye directly reveals activated proteins in living cells
4. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
5. Scientists discover proteins involved in spread of HIV-1 infection
6. New mechanism for display of foreign proteins to immune system
7. Scientists visualise cellular handmaiden that restores shape to proteins
8. Hopkins scientists use blood proteins to detect ovarian cancer
9. Viral proteins may prevent bacterial infections
10. Misfiring proteins tied to inflammation and sick feeling of type 2 diabetics
11. Good bacteria trigger proteins to protect the gut

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech , ... dialogue, today announces its inaugural South CEO conference to be held ... , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to discuss ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... ... its technology driven portfolio of 3D porous titanium spinal implants with the expansion ... Ti3D implant offerings while more than tripling the number of cervical and lumbar ...
(Date:9/22/2019)... ... September 20, 2019 , ... ... are adjusting to client demands for precision medicine products. The report, Lab ... $19 billion in 2018, the pharma/bio sector is the largest source of demand ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... VEGAS (PRWEB) , ... October 10, 2019 , ... R3 ... courses. The next course is October 18-19th, 2019 in Las Vegas with spots still ... exosomes. He completed training at several Ivy League universities including Cornell, Harvard and Dartmouth. ...
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, ... announced the midway point of its randomized research trial for individuals with persisting ... measure the efficacy of a non-invasive technology which compares tones delivered to a ...
(Date:10/3/2019)... Ontario (PRWEB) , ... October 02, 2019 , ... ... sequencing using mass spectrometry, is pleased to announce that it has moved into ... spectrometers among other analytical instruments, the new facility demonstrates the company's continuous commitment ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and ... company focused on the development of therapies to treat central nervous system ...
Breaking Biology Technology:
Cached News: